DipCatcher by KAWUMSFRAclosedLONclosedNYCclosed
€FRA…
£LON…
$NYC…
₿BTC24/7
Next analysis …Last run 8:30 am · 0 4–5 ★ · 28 3 ★
Market
IREN$21.64+20.0%AXON$313.00-18.2%CIFR$6.55+17.9%TEAM$153.68-16.2%HUT$52.65+14.6%COHR$192.81+13.6%RIOT$16.71+13.2%STM.DE€14.24-12.0%ABNB$189.99+11.7%SHIB$0.0000+11.3%AMD$449.04+11.0%VST$124.80+10.6%HFG.DE€2.99-10.4%MCHP$58.35-10.0%APP$391.22+9.9%NRG$88.29+9.6%SPCX$134.27+8.6%CLSK$6.16+8.5%LRCX$200.44+8.2%MARA$6.35+8.0%CRL$337.52+7.8%INTC$56.28+7.7%EMG.L297.00 p-7.6%ANET$170.80+7.3%AKAM$83.09+6.7%KLAC$138.49+6.7%BT-A.L217.00 p-6.4%Q$117.00+6.3%PWR$540.90+6.3%HAG.DE€77.44-6.2%GFS$38.62+6.2%SMCI$28.76+6.2%CHTR$118.07-6.2%PODD$146.51-6.2%DXCM$79.41-6.0%CNC$69.74-6.0%MRVL$141.20+5.7%LITE$538.59+5.7%HOT.DE€365.60+5.5%QCOM$165.41+5.5%CIEN$243.39+5.5%FIX$1,017.50+5.4%HUM$433.74+5.3%MRNA$254.19+5.3%GLXY$13.66+5.2%ECHO$94.62+5.2%MPWR$1,190.44+5.2%MU$690.00+5.1%AIXA.DE€30.41+5.1%ASML$1,424.75+5.0%NDX1.DE€42.98+5.0%VTRS$19.91+5.0%DLTR$131.14-4.9%EXPE$259.24-4.9%NEM.DE€64.75-4.8%GDDY$114.38-4.8%WYNN$83.11+4.8%BKNG$160.66-4.8%ARM$174.62+4.7%BEN$33.73+4.7%

Bio-Techne

$72.78+0.2% today

TECH · NASDAQ · USD · Healthcare

As of 1:45 am

Price

+0.8% since 07/08/2026
signal6-week high$72.8307/08/202623/09/202607/11/2026

3 months · High $72.83 (-0.1%) · Low $71.88

1What is happening

Bio-Techne has fallen 0% since its 6-week high on 04/11/2026. How it continues – phase and signs – you see with a free account.

Free account · 3 stocks and coins a day

from the 6-week high-0.1%

Other view · 10 analystsHorizon: 12 months0 Buy · 12 Hold · 1 Sell

2Our assessment

No dip42

How it continues – phase and signs – you see with a free account.

3Your next step

Marking places no order – it only helps you keep track.

More details · reasons, figures, alerts

How deep is the dip?

  • from the 6-week high-0.1%

    Highest daily price: $72.83 on 04/11/2026 · reference of the assessment · also the highest of the last 3 months

  • from the 52-week high-0.1%

    Highest price in 52 weeks: $72.83 (Yahoo)

What analysts expect

10 analysts disagree. They look about 12 months ahead – DipCatcher only 14 trading days.

Buy
00 %
Hold
1292 %
Sell
18 %

Average price target$70.50

$50.00 to $73.00 · today $72.78

$50.00Ø $70.50$73.00

What is a price target?

The price an analyst expects in about 12 months. Estimates are often far apart and change frequently.

Third-party opinion, not an assessment by DipCatcher. Source: public analyst estimates, as of 08/11/2026. Not financial advice.

Dates

The company in figures

Market value
11.4 bn $
All shares together at the current price.
P/E
62.7
Price divided by earnings per share, last 12 months.
Dividend yield
0.44 %
Yearly dividend relative to the price.
52-week range
$43.20 – $72.83
Lowest and highest price of the last year.
Your move on this one?Sign in to record it
Your take on this verdict?Sign in to react

Catalysts

35 h ago
News, last 10 days
no recent news
Next earnings
09/11/2026 · in 3 days
Last report
12/08/2026 +0.1% vs estimate

Key figures

Market value
11.4 bn $Large cap
P/E
62.7
Dividend yield
0.44 %
Volume today
0.7 × Øabout usual
Beta
1.28swings about like the market
52-week range
$43.20 – $72.83price at 100 % of the range

Earnings within 3 days: results can move the price either way. The score is held back until they are out.

About Bio-Techne

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. Its Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Headquarters:
Minneapolis, United States
52-week range:
$43.20 – $72.83

Trade levels

Why the engine says so

History for this stock or coin

Watch and alert

See which stocks they are

The engine is watching these dips right now. A free account shows the names and opens 3 full analyses a day.

  • 3 full analyses a dayWith entry, target, stop and the reasons behind them.
  • WatchlistFollow the stocks you care about.
Create a free account

Free, no payment details.

Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search

Not investment advice. Investing carries risk up to total loss.